5247 |
The Future of PCI: Contemporary Optimal Indication, Technology, and Outlook |
Robert A. Byrne |
Apr. 12. 21 |
5246 |
Managing LDL-C with Praluent: Identifying the Patients, Optimizing the Outcomes |
Yongwhi Park |
Apr. 12. 21 |
5245 |
From Sustainable Lipid Management to Life-Saving CV Protection for ACS Patients |
Ki Hoon Han |
Apr. 12. 21 |
5244 |
Right Time to Reverse Cardiac Remodeling with ARNI |
Jeong Su Kim |
Apr. 12. 21 |
5243 |
Reinforce Strategies to Improve Outcomes in POST-MI Heart Failure |
Do-Yoon Kang |
Apr. 12. 21 |
5242 |
Cocktail Therapy for Unusual Calcified Lesion , the Road to Success |
Alan Chan |
Apr. 12. 21 |
5241 |
When and Why OAS Works Better for Calcified Lesions ? |
Michael S. Lee |
Apr. 12. 21 |
5240 |
My Most Frightening Rotablation Case |
Yoshifumi Kashima |
Apr. 12. 21 |
5239 |
Functional MR - Percutaneous Treatment Considerations |
Samir R. Kapadia |
Apr. 12. 21 |
5238 |
Coronary Access Post TAVI |
Danny Dvir |
Apr. 12. 21 |